Neurocrine Biosciences | 유동 자산

Current Assets 변화 날짜
AbbVie USD 33.22B 4.37B 2023-09
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
ALKERMES USD 1.46B 67.43M 2023-09
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Cytokinetics USD 628.05M 66.63M 2023-12
Dynavax Technologies USD 859.12M 23.45M 2023-12
Exelixis USD 1.44B 147.16M 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Incyte USD 4.65B 242.74M 2023-12
Intra Cellular Therapies USD 667.8M 34.63M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Repligen USD 978.46M 20.13M 2023-09
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Teva Pharmaceutical Industries USD 11.42B 663M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Neurocrine Biosciences 유동 자산 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.